Venous Leg Ulcers (Crural ulcer) Pipeline Review Report 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2017" report to their offering.

Venous leg ulcers develop when persistently high blood pressure in the veins of the legs (venous hypertension) causes damage to the skin, which eventually breaks down and forms an ulcer. Symptoms include swollen ankles filled with fluid that temporarily hold the imprint of finger when pressed (known as pitting edema), discoloration and darkening of skin around the ulcer (known as hemosiderosis), hardened skin around the ulcer, which may make leg feel hard and resemble the shape of an upside-down champagne bottle (known as lipodermatosclerosis), small, smooth areas of white skin, which may have tiny red spots (known as atrophie blanche).

The Venous Leg Ulcers (Crural ulcer) (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Venous Leg Ulcers (Crural ulcer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Unknown stages are 3, 7, 1, 5 and 1 respectively.

Venous Leg Ulcers (Crural ulcer) (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Key Topics Covered:

  1. Introduction
  2. Venous Leg Ulcers (Crural ulcer) Overview
  3. Therapeutics Development
  4. Pipeline Products for Venous Leg Ulcers (Crural ulcer) - Overview
  5. Pipeline Products for Venous Leg Ulcers (Crural ulcer) - Comparative Analysis
  6. Venous Leg Ulcers (Crural ulcer) - Therapeutics under Development by Companies
  7. Venous Leg Ulcers (Crural ulcer) - Therapeutics under Investigation by Universities/Institutes
  8. Venous Leg Ulcers (Crural ulcer) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Venous Leg Ulcers (Crural ulcer) - Products under Development by Companies
  13. Venous Leg Ulcers (Crural ulcer) - Products under Investigation by Universities/Institutes
  14. Venous Leg Ulcers (Crural ulcer) - Companies Involved in Therapeutics Development
  • Adocia
  • CardioVascular BioTherapeutics Inc
  • CytoTools AG
  • Factor Therapeutics Ltd
  • FirstString Research Inc
  • Mallinckrodt Plc
  • MediWound Ltd
  • NovaLead Pharma Pvt Ltd
  • Promore Pharma
  • RegeneRx Biopharmaceuticals Inc
  • RMB-Research GmbH

For more information about this report visit http://www.researchandmarkets.com/research/hzdfx7/venous_leg_ulcers

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Drugs, Cardiovascular Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Drugs, Cardiovascular Drugs